News details - novonordisk-us.com
4 days ago · PLAINSBORO, N.J., Jan. 28, 2025 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic ® to reduce the risk …
F.D.A. Approves Ozempic to Treat Kidney Disease
4 days ago · The F.D.A. based its decision to expand the approved uses of Ozempic on research showing that people with Type 2 diabetes and chronic kidney disease who took the drug had a …
FDA approves Ozempic to reduce risks from chronic kidney disease …
3 days ago · Novo Nordisk is conducting a different study to understand how and why semgalutide seems to reduce the progression of kidney disease, said Stephen Gough, global …
FDA OKs Ozempic for Kidney Disease in Diabetes Patients
3 days ago · Jan. 29, 2025 -- The FDA has approved Novo Nordisk's diabetes drug Ozempic to help reduce the risk of worsening kidney disease, kidney failure, and heart-related death in …
US FDA Approves Novo Nordisk's Ozempic to Cut Risk of Diabetic Kidney …
3 days ago · (Reuters) -The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes …
FDA clears use of Ozempic to protect kidney health
3 days ago · Novo Nordisk on Tuesday won an expanded approval for Ozempic, allowing the company to market its top-selling medicine to reduce the risk of kidney complications in adults …
Ozempic Approved By FDA For Chronic Kidney Disease - Forbes
3 days ago · The agency cited findings from a late-stage trial by Novo Nordisk, which reported in March 2024 that—in a trial of more than 3,500 people with type 2 diabetes—Ozempic lowered …
US FDA approves Novo Nordisk's Ozempic to cut risk of diabetic kidney …
3 days ago · The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients …
Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease …
Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type 2 diabetes and chronic kidney disease, Novo Nordisk said.
FDA approves Ozempic® (semaglutide) as the only GLP-1 RA to …
3 days ago · PLAINSBORO, N.J., Jan. 28, 2025 /PRNewswire/ -- Novo Nordisk today announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic ® to reduce the risk …
- Some results have been removed